Randomized trial · people

Kisspeptin-10: daily 8 h infusions kept LH raised for 12 days in men

Checked against the paper Randomized trialPublished by PepVault

The takeaway

In healthy men, an on-off daily schedule of kisspeptin-10 kept LH and FSH rises going for 12 days, while nonstop infusion lost the LH and FSH effect by day 5.

Kind
Randomized trial
Studied in
People
Number studied
15
Published
2026
Journal
Eur J Endocrinol

What they tested

The team tested whether kisspeptin-10 given under the skin over days could keep reproductive hormones raised in healthy men, and which schedule worked best.

How the study was done

A randomized, single-blinded, placebo-controlled study in 15 healthy men split across three parts (7, 4 and 7 men), with 12 men acting as controls. Men first got single 8 h under-the-skin infusions at 1.25-10.0 nmol/kg/h, then either a nonstop 5-day infusion (180 nmol/h) or 12 days of one 8 h infusion each day (150 nmol/h).

A woman in glasses at a kitchen table with a laptop, a mug and her phone

PepVault for iPhone

Taking Kisspeptin-10? Keep your own record

Log each dose, your weight and how you feel, in one place.

Download on the App Store

7 days free on the yearly plan for new subscribers.

What they found

Single 8 h infusions raised LH (luteinizing hormone), FSH (follicle-stimulating hormone) and testosterone more as the dose went up, compared with vehicle, the inactive carrier solution. With the nonstop 5-day infusion, testosterone stayed raised, but LH and FSH ended up similar to vehicle. With daily 8 h infusions, the mean LH rise was +1.68 ± 0.25 on day 1 and +1.14 ± 0.33 on day 12, versus -0.16 ± 0.19 with vehicle, a significant difference. After the 12 days, a 1 nmol/kg bolus (a single quick dose) of kisspeptin-10 still raised LH and FSH, which the team read as a sign the kisspeptin receptor still worked.

What it doesn’t show

Each part of the study had only 4 to 7 men, all healthy, and the longest schedule lasted 12 days. It did not test people with reproductive disorders, women, or longer use.

The paper

Yeung et al. Chronic subcutaneous kisspeptin-10 stimulates gonadotropin secretion for 12 days in healthy men. Eur J Endocrinol. 2026.

The compound

More studies on Kisspeptin-10

Researched and drafted with AI, then checked claim by claim against the primary sources linked below by a separate review pass. Published by PepVault. Last reviewed . Spot an error? feedback@pepvault.app. How we research. This page reports one study; it is not medical advice.

Track it in the app

PepVault for iPhone

Taking Kisspeptin-10? Keep your own record

Log each dose, your weight and how you feel, in one place.

Download on the App Store

7 days free on the yearly plan for new subscribers.

Explore the live demo